DSpace Repository

Statins Inhibit HIV-1 infection by down-regulating rho activity

Show simple item record

dc.creator Real, Gustavo del
dc.creator Jiménez Baranda, Sonia
dc.creator Mira, Emilia
dc.creator Lacalle, Rosa Ana
dc.creator Lucas, Pilar
dc.creator Gómez-Moutón, Concepción
dc.creator Alegret, Marta
dc.creator Peña, José María
dc.creator Rodríguez Zapata, Manuel
dc.creator Álvarez-Mon, Melchor
dc.creator Martínez-Alonso, Carlos
dc.creator Mañes, Santos
dc.date 2008-03-27T08:01:58Z
dc.date 2008-03-27T08:01:58Z
dc.date 2004-08
dc.date.accessioned 2017-01-31T01:00:57Z
dc.date.available 2017-01-31T01:00:57Z
dc.identifier The Journal of Experimental Medicine, volume 200, number 4, august 16, 2004, pp. 541–547
dc.identifier 0022-1007
dc.identifier http://hdl.handle.net/10261/3323
dc.identifier doi/10.1084/jem.20040061
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3323
dc.description Copyright © by The Rockefeller University Press
dc.description Human immunodeficiency virus (HIV)-1 infectivity requires actin-dependent clustering of host lipid raft–associated receptors, a process that might be linked to Rho guanosine triphosphatase (GTPase) activation. Rho GTPase activity can be negatively regulated by statins, a family of drugs used to treat hypercholesterolemia in man. Statins mediate inhibition of Rho GTPases by impeding prenylation of small G proteins through blockade of 3-hydroxy-3-methylglutaryl coenzyme A reductase. We show that statins decreased viral load and increased CD4 cell counts in acute infection models and in chronically HIV-1–infected patients. Viral entry and exit was reduced in statin-treated cells, and inhibition was blocked by the addition of l-mevalonate or of geranylgeranylpyrophosphate, but not by cholesterol. Cell treatment with a geranylgeranyl transferase inhibitor, but not a farnesyl transferase inhibitor, specifically inhibited entry of HIV-1– pseudotyped viruses. Statins blocked Rho-A activation induced by HIV-1 binding to target cells, and expression of the dominant negative mutant RhoN19 inhibited HIV-1 envelope fusion with target cell membranes, reducing cell infection rates. We suggest that statins have direct anti–HIV-1 effects by targeting Rho.
dc.description Peer reviewed
dc.format 861610 bytes
dc.format application/pdf
dc.language eng
dc.publisher Rockefeller University Press
dc.rights openAccess
dc.subject Cholesterol
dc.subject Actin cytoskeleton
dc.subject Small GTPases
dc.subject Lipid rafts
dc.subject Prenylation
dc.title Statins Inhibit HIV-1 infection by down-regulating rho activity
dc.type Artículo


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account